ArticleOncotarget2017

Activation of cancerous inhibitor of PP2A (CIP2A) contributes to lapatinib resistance through induction of CIP2A-Akt feedback loop in ErbB2-positive breast cancer cells.

Ming Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.